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Australian bat lyssavirus (ABLV), which occurs in pteropid and insectivorous bat populations, causes a rabies-like
encephalitis in infected humans. We report the first complete sequence of an ABLV isolate obtained from a human who
developed symptoms 27 months after being bitten by an infected flying fox. This isolate is the smallest lyssavirus to be
sequenced, with a size of 11,918 nucleotides. Analyses of previously unsequenced regions and the complete genome confirm
its close relationship with classical rabies viruses. In addition, a leucine zipper-like motif, not present in the other
lyssaviruses, was found in the conserved domain I of the polymerase protein. This is the first report of a lyssavirus to vary
in an 11-nucleotide, strictly conserved, complementary terminal sequence. This region is thought to encode important
cis-acting regulatory signals; ABLV variation indicates a greater degree of flexibility than was thought for lyssaviruses in this
region. A comparison of the pteropid and insectivorous isolates of ABLV indicates considerable differences between the twoINTRODUCTION
Australian bat lyssavirus (ABLV) is a negative-strand
nonsegmented RNA virus of the order Mononegavirales,
family Rhabdoviridae, genus Lyssavirus. It was first iden-
tified in an encephalitic bat in 1996 (Fraser et al., 1996).
Subsequently, a rabies-like encephalitis after human in-
fection with ABLV was reported. The initial case was a
39-year-old female presumably infected by a yellow-bel-
lied sheathtail bat (Saccolaimus flaviventris) in her care
in 1996 (Allworth et al., 1996). A second infection was a
37-year-old woman identified with ABLV encephalitis in
1998 (Hanna et al., 2000). The incident where this infec-
tion most likely occurred, a bite by an unidentified spe-
cies of flying fox, indicated that she had had a latent
period of approximately 27 months. ABLV exposure has
been demonstrated in the insectivorous yellow-bellied
sheathtail bat (suborder Microchoptera) and four species
of frugivorous flying foxes (suborder Megachoptera; spp.
Pteropus alecto, Pteropus poliocephalus, Pteropus
scapulatus, and Pteropus conspiculatus) and, hence,
these animals are thought to be the likely natural reser-
voirs for the virus (Hooper et al., 1997; McCall et al.,
2000).
There are four serotypes in the lyssavirus genus
(Dietzschold et al., 1987; Schneider et al., 1973). On the
basis of the nucleocapsid gene sequence they can be
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2109divided into classical rabies (genotype 1), Lagos bat
(genotype 2), Mokola (genotype 3), Duvenhage (genotype
4), and European bat lyssavirus type 1 and 2 (genotypes
5 and 6, respectively) (Tordo et al., 1993). Australian bat
lyssavirus can be distinguished genetically; it is classi-
fied as genotype 7, but is serologically closely related to
rabies (Gould et al., 1998). More recently, separation of
lyssaviruses into two phylogroups based on genotype,
cross-neutralisation, and pathogenicity data were pro-
posed (Badrane et al., 2001). Phylogroup I consists of
classical rabies, Duvenhage, the European bat lyssavi-
ruses 1 and 2, and Australian bat lyssavirus. Phylogroup
II includes Mokola and Lagos bat viruses.
The sequence of the nucleocapsid (N), phosphopro-
tein (P), matrix (M), glycoprotein (G), and the N-terminal
of the RNA polymerase (L) of the pteropid (Gould et al.,
1998) and insectivorous ABLV isolates is known (Gen-
Bank Accession No. AF08120). However, up to the
present, the complete genome sequence of an isolate of
ABLV has not been reported. Unlike the situation with
rabies in America and Europe, there seems to be little
temporal, geographic, or species variation within flying
fox populations in Australia (Ina L. Smith, unpublished
observations). The nucleotide sequence of the nucleo-
capsid region of isolates from 16 pteropid bats is highly
conserved (Hooper et al., 1997). It is generally consid-
ered that pteropid and insectivorous isolates are very
similar (Hooper et al., 1997); however, a thorough molec-
ular analysis has never been published.
In this work we report the first complete genome
sequence of a human isolate of ABLV from the secondviruses. If the divergence of the two occurred on the Aust
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termini revealed a unique difference in the conserved
11-nucleotide complementary terminal region. In addi-
tion, a leucine zipper-like motif, not present in the other
lyssaviruses, was found in the conserved domain I of the
RNA polymerase protein. A phylogenetic analysis was
also conducted on the polymerase, a region often used
in determining the relationship of distantly related vi-
ruses, which supported previous similarities to rabies. A
phylogenetic analysis of the nucleocapsid region con-
firmed that the human isolate was closely associated
with the pteropid strain, as expected. Comparison of the
pteropid and insectivorous strains revealed that there
are considerable differences between the two strains.
The synonymous and nonsynonymous nucleotide
changes were used to calculate the temporal separation
of the two isolates at 950 and 1700 years, respectively.
RESULTS AND DISCUSSION
Cloning and sequencing of a human isolate of ABLV
The sequence of a pteropid isolate of ABLV including
the N, P, M, G, and the start of the L open reading frame
(ORF) (Gould et al., 1998) was used to design deoxyoli-
gonucleotide primers to amplify 13 overlapping PCR
products of ABLV ranging in size from 419 to 740 nt.
These amplicons were directly sequenced to obtain a
contiguous length of sequence spanning nucleotides
82–5392 (Fig. 1). To determine specific sequence infor-
mation further downstream, an alignment of the L protein
sequence of rabies and Mokola viruses revealed a re-
gion of evolutionary conservation in the carboxyl-termi-
nal region of the L protein (data not shown) suitable for
the design of degenerate primers ABL1 and 2. This
region corresponded to the conserved domain (amino
acids 1904–1935 of L)—of which there are six in the RNA
polymerase of the nonsegmented negative-strand RNA
viruses—that is closest to the carboxyl-terminus of the
protein (Le Mercier et al., 1997). Amplification with prim-
ers ABL1 and 2 generated a product approximately 100
bp in size that was cloned and sequenced. Based on
sequence information from the 100-bp product, specific
upstream and downstream primers were designed. Long
PCR was then used to amplify a 5.8-kb amplicon using
the specific primers. Sequencing of this product enabled
90% of the L protein sequence to be obtained.
To obtain the terminal sequences of ABLV, the rapid
amplification of cDNA ends (RACE) was employed. For
the 5 terminus, an 800-bp product was obtained after
two rounds of amplification, each round using a different
specific primer. Sequencing of the product and compar-
ison with the termini of other lyssaviruses confirmed it to
be the 5 authentic terminal sequence of ABLV (Fig. 2A).
To amplify the 3 terminus, it was first necessary to add
a poly(A) tail to the genomic viral RNA template synthet-
ically using poly(A) polymerase as the rhabdovirus
genomic RNA is not polyadenylated. After two rounds of
amplification, using a different specific primer for each
round, a product of approximately 150 bp was obtained.
Sequencing also confirmed the authenticity of the 3-
terminal sequence (Fig. 2B).
Structure and features of the ABLV genome
The ABLV total genome length is 11,918 nucleotides,
which is the smallest of the lyssaviruses sequenced so
far, and compares with Mokola, which has the largest
genome size of 11,940 nucleotides, and rabies, which
ranges in size from 11,926 (RC-HL) to 11,932 (PV) nucle-
otides. It is interesting to note that of the lyssavirus
genomes to be sequenced to date, all have been found
to have an even number of nucleotides. This may be a
requirement for efficient replication and equivalent to the
paramyxovirus “rule of six.” However, a restriction to
even-numbered genome length, if there is one, does not
seem to apply to the other rhabdoviruses. ABLV differs
from the other lyssaviruses in departing from a con-
served 11-nucleotide sequence that is complementary at
opposing termini. This region is thought to contain sig-
nals for encapsidation or transcription/replication initia-
tion. This change from the 11-nucleotide sequence indi-
cates that there is a greater degree of flexibility in the
terminal sequences than was previously thought in this
group of viruses.
A search for potential ORFs revealed five large areas
of sequence corresponding, in order from the 5 antige-
FIG. 1. cDNAs sequenced to obtain the genome of ABLV. All clones were sequenced in both directions. A, 3 RACE clones; B–N, overlapping RT-PCR
amplicons; O, 5.8-kb RT-PCR clones; P, 0.1-kb RT-PCR clone; and Q, 5RACE clones.
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nomic terminus, to lyssavirus proteins N, P, M, G, and L.
Assuming that the second ATG is the preferred initiation
codon for the M protein, as has been suggested (Gould
et al., 1998), the total coding capacity of the genome
ABLV is 90.7% with the L protein accounting for 53.5% of
the genome. The genome was slightly A/U rich (57%)
with significantly higher occurrences (mean of 745) of the
dinucleotides GA (927), AA (914), AU (951), UU (977), CU
(910), and UC (1013) and lower occurrences of CG (233)
and GC (359). The significance of these nucleotide/dinu-
cleotide frequencies to the lifecycle of the virus is not
known.
The close similarity between rabies and ABLV has
been recognized (Fraser et al., 1996; Gould et al., 1998;
Hooper et al., 1997). To explore this observation further,
ABLV was compared with the rabies vaccine strain SAD
B19. A global alignment of the complete ABLV genome
with rabies SAD B19 revealed a 72.4% sequence identity,
providing support for a close genetic relationship be-
tween the two viruses. An alignment of SAD B19 with
ABLV clearly illustrates sequence similarity along most
of the length of the genome, particularly the 5-terminal
half of the genome that encodes the putative RNA poly-
merase (L protein) (data not shown). Regions of lower
sequence identity are the 3-noncoding region of G and
P regions, as has been noted for rabies (Conzelmann et
al., 1990) and ABLV (Gould et al., 1998), respectively.
Gaps in the alignment between the two viruses were
only found in the untranslated regions (UTR) between the
N/P, P/M, M/G ORFs, and 3 noncoding region of G, with
the majority of alignment gaps clustering in the 3-non-
coding region of G.
Properties of the untranslated regions
The 3-noncoding region of G of ABLV has 46.1% se-
quence identity with SAD B19, reflecting the poor evolu-
tionary conservation of this region between rabies and
ABLV. Two transcription termination and polyadenylation-
like (TTP) sequences exist in the 3-noncoding region of
the G of some related rabies strains (Ravkov et al., 1995).
It has been suggested that the TTP signal closest to the
G ORF terminates the glycoprotein gene while the down-
stream TTP is the remnant of an ancestral ORF. The
absence of the upstream TTP in wild rabies strains
indicates that the upstream TTP is a feature of the com-
mon ancestry of some laboratory strains and may be
nonfunctional (Ravkov et al., 1995). The absence of an
upstream TTP in Mokola and in the ABLV genome sup-
ports the view that the 3-noncoding region of the glyco-
protein transcript is in fact a long untranslated region
with unknown function.
Differences were observed between the transcription
initiation and termination signal of the human ABLV iso-
late and the flying fox isolate. The sizes of the N/P to M/A
intergenic spacer regions (IGS) of the human isolate
(Table 1) were identical to SAD B19 (Conzelmann et al.,
1990) but were one base smaller than the M/G IGS of the
flying fox isolate (Gould et al., 1998). In addition, the
transcription stop signal in the N/P-untranslated region
in the human isolate (3-A/TCU7G-5) corresponded more
closely with the consensus sequence than the flying fox
isolate (3-A/TCU6G-5).
The transcription initiation and stop signals for the
human ABLV isolate (Table 1) matched consensus sig-
FIG. 2. The ABLV 5- and 3untranslated terminal regions. Multiple sequence alignment of (A) the 5 131 nucleotides and (B) the 3 70 nucleotides
of the untranslated regions of ABLVh with rabies (SAD and PV strains) and vesicular stomatitis virus Indiana serotype (VSIV) and bovine ephemeral
fever virus (BEFV). The sequence is genomic sense and oriented 5–3 for 5 terminus and 3–5 for the 3 terminus. (C) Alignment of the 3 terminal
32 nucleotides of the genomic RNA with the complement of the first 32 nucleotides at the 5 terminus. The sequence is 3–5 orientation.
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nals for the lyssaviruses (Bourhy et al., 1989) with the
exception, interestingly, of the P/M transcription termina-
tion signal (3-A/TCUCU5G-5). The ABLV patient experi-
enced an exceptionally long incubation period of 27
months. It was thought possible that downstream effects
on transcription initiation at the matrix protein gene may
have contributed to the long incubation period. To deter-
mine whether this sequence variant was present in the
original brain material, viral RNA covering the P/M-un-
translated region was amplified from RNA extracts of the
patient’s brain stem, cerebellum, Ammons Horn, and left
and right cerebral hemispheres of the patient.
Direct sequencing of the amplicons revealed that the
consensus transcription termination signal was present
in all the original brain material (data not shown), indi-
cating that the departure from the consensus signal may
be a feature of the adaptation of the virus to cell culture,
and not a feature of the infecting virus. This is not
unexpected as rabies has been shown to undergo atten-
uation after passage on cultured cells (Blancou et al.,
1983). Interestingly, a mutation in the phosphoprotein
transcription termination in Mokola virus that reduced
the genomic polyadenylation signal from seven to six U
residues was associated with production of a bicistronic
transcript (Bourhy et al., 1990). Based on the observa-
tions with VSV (Whelan et al., 2000), the changes at the
phosphoprotein transcription termination sequence
would be expected to reduce termination of the phos-
phoprotein transcript leading to reduced initiation at the
matrix transcription start site and an increase in a bicis-
tronic P/M read-through transcript. This would result in
reduced levels of matrix protein. However, it is not known
how this would assist the virus to adapt to cell culture. A
comparison of the sequence of the attenuated rabies
strain RC-HL with the parental Nishigahara strain re-
vealed a change from 3-AC(U)7-5 to 3-CC(U)7-5 at the
genomic phosphoprotein transcription termination se-
quence in RC-HL (Ito et al., 2001).
ABLV has 70 and 131 nucleotide UTRs at its 3 and 5
termini, respectively (Figs. 2A and 2B); this includes nine
nucleotides of an identical complementary terminal se-
quence (Fig. 2C). This differs from all other lyssaviruses
sequenced to date that have 11 nucleotides of an iden-
tical complementary sequence at their termini (Bourhy et
al., 1990). Interestingly, this is a result of the fact that the
3 terminus differs at nucleotide position 10 from the
conserved sequence, in comparison to the 5 terminus
that has the conserved 11-nucleotide sequence. Presum-
ably, the additional 5-terminal G residue at the Mokola
sequence (Fig. 2A) is a GenBank entry error, as the
authors have previously commented on the exact
complementarity of the 11-nucleotide sequence of this
virus (Bourhy et al., 1990). This departure from the exact
11-nucleotide complementary sequence at the 3 end
was also seen in the original patient brain material and
also in a pteropid isolate (data not shown), indicating it is
a feature of the wild-type virus. In addition, the terminal
complementarity of ABLV extends to 23 of the terminal 32
nucleotides (Fig. 2C).
The genomic 3UTR of ABLV is U rich, while the 5
UTR—reflecting the above described complementar-
ity—is A rich. An alignment of termini from the lyssavirus
genus and including other representative rhabdoviruses
from the genera ephemerovirus and vesiculovirus shows
three conserved nucleotides at the 3 terminus, with its
complement conserved at the 5 terminus (Figs. 2A and
2B). Rhabdoviruses infecting fish and plants did not give
meaningful alignments for this region. At the 3UTR this
is proceeded by a series of irregularly spaced and con-
served U residues that extend along the length of the
UTR, but are concentrated toward the terminus, and
additionally, two conserved G residues. Three of the
conserved U residues and one of the G residues corre-
spond to part of the transcription termination and initia-
tion signals present in the 3UTR. At the 5UTR, a series
of A residues is irregularly spaced to nucleotide 32.
However, these A residues are not positioned to be
complementary to the conserved U residues at the
3UTR.
It is interesting to speculate that these conserved
nucleotides may have an important role in replication
such as an encapsidation signal or may act as a repli-
cation/transcription initiation signal. By analogy with VSV,
the encapsidation assembly site of the ABLV leader may
reside within 14 nucleotides of the 3 terminus, most
probably in a triplet phase repeat of A residues (Blum-
berg and Kolakofsky, 1983). Four of five of these con-
served leader A residues correspond to the conserved
complementary U residues in the 3-terminus alignment
of the rhabdoviruses in the genomic strand. The fact that
the conserved U residues at the 5 end do not overlap
with the conserved complementary A residues at the 5
end indicates a requirement for U-rich sequences rather
than position for functional signals at the termini. A
conserved transcription termination signal is also
present in the 5UTR. We are currently nearing comple-
tion of a reverse genetics system for ABLV to explore
these and other aspects of rhabdovirus replication.
TABLE 1
Transcription Initiation and Termination Signals
of Australian Bat Lyssavirusa
Region Stop IGS Start
Leader/N UUCGUUUUUAC 1 UUGUGGGGA
N/P UCUUUUUUUG 2 UUGUGGGGA
P/M ACUCUUUUUG 5 UUGUGGUGA
M/G ACUUUUUUUG 5 UUGUGGGGA
G/L ACUUUUUUUG 19 UUGUAAGGA
L/trailer ACUUUUUUUG — —
a Sequence is presented in the 3-5 genomic sense orientation.
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Some of the conserved U residues may have dual
roles in encapsidation at the 5 end and transcription/
replication at the 3 end of genomic and antigenomic
RNA. For VSV, the genomic strand, nucleotides 1–15 from
the 3 terminus are sufficient for a low level of replication
(Whelan and Wertz, 1999), while deletion of nucleotides
1–6, 7–12, and 13–18 drastically reduced replication and
transcription (Li and Pattnaik, 1999). Interestingly, these
deletions did not stop encapsidation. In addition, the
terminal 3-UGC-5 was a requirement for replication/
transcription activity in vitro. Nucleotides from 19–50
were important for efficient transcription (Whelan and
Wertz, 1999). For the antigenomic strand, 15 nucleotides
from the 3 terminus was sufficient for low-level replica-
tion. An encapsidation signal also resides in the 5 end,
or trailer region, of the genomic RNA (Whelan and Wertz,
1999).
Identity scores calculated from pair-wise alignments
of the 5- and 3UTRs of lyssaviruses and the represen-
tative ephemerovirus BEFV is given in Table 2. As there
were considerable size differences in the UTR of VSV
with the lyssaviruses (Figs. 2A and 2B) and BEFV, VSV
was not included in the analysis. To avoid problems with
the heterogeneous length of the 5UTR, the analysis was
conducted on the region from the terminus to the tran-
scription termination signal. For the lyssaviruses, the
3UTR is generally more evolutionarily conserved. Both
UTRs reflect the closer phylogenetic relationship be-
tween ABLV and rabies, with Mokola more distant to
both.
Properties of the predicted ORFs
As the human isolate was from an infection transmit-
ted by a flying fox bite, it was expected that the sequence
would be nearly identical to a published flying fox isolate
for ABLV. Indeed, there was a 98.3% nucleotide se-
quence identity between the two isolates from the nu-
cleocapsid coding region to the amino terminus of L.
However, the carboxyl-terminal region of the predicted
amino acid sequence of G differed from the flying fox
sequence (Fig. 3). The alignment indicated an additional
amino acid residue in the human isolate in comparison
to the flying fox isolate (Gould et al., 1998). This was also
the case for an insectivorous bat isolate for this region of
the glycoprotein (GenBank Accession No. AF08120). This
might indicate a variable domain as there are size dif-
ferences of two and four amino acid differences between
the human isolate and rabies and Mokola viruses, re-
spectively (Fig. 3). An analysis of the predicted N, P, M,
and G proteins of a flying fox isolate has been done
previously (Gould et al., 1998). A comparison of the dif-
ferences in the predicted amino acid sequence of the
human and pteropid isolates is given in Table 3. In
addition, these changes were confirmed by amplification
and sequencing of the original brain material. The amino
acid sequence of the cell culture adapted ABLV was
identical to that present in the amplified brain material
TABLE 2
Sequence Identity Scoresa for Rhabdovirus 3 and 5 UTRsb (%)
ABLVh SAD PV MOK BEFV
ABLVh — 81.4 75.7 70.0 49.3
SAD 70.9 — 92.9 80.0 44.9
PV 72.2 96.2 — 80.0 42.0
MOK 63.3 64.6 63.3 — 44.9
BEFV 51.9 44.9 46.2 48.7 —
a Identity scores for the 3 termini are given above the diagonal and
for the 5 termini are given below the diagonal.
b 3 UTR analysis includes nucleotides 1–70; 5 UTR analysis in-
cludes nucleotides 11,839–11,918.
FIG. 3. The variable carboxyl-terminal domain of the glycoprotein of
lyssaviruses. The carboxyl-terminal domain of the glycoprotein of the
human isolate (ABLVh) is aligned with the pteropid (ABLVp) and insec-
tivorous (ABLVi) isolates, and Mokola (MOK) and rabies strains SAD
B-19 (SAD) and PV. The variable region is underlined.
TABLE 3
Comparison of the Deduced Amino Acids between the Human and
Pteropid Isolates of ABLV
Protein Amino acid position Human Pteropid
Nucleocapsid 34 K Q
36 Q H
37 K T
95 L M
362 N D
401 G S
Phosphoprotein 66 L S
67 V A
74 E D
135 S N
218 L Q
263 L P
Matrix 26 P T
135 E Q
Glycoprotein 348 K N
349 S Q
403 V I
425 K Y
467 V I
517 I L
518 E K
519 A P
520 G S
521 G —
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with one exception. Amino acid 362 of the nucleocapsid
was an asparagine in the cell culture adapted virus, but
was an aspartic acid in the original brain material and,
interestingly, the pteropid isolate. The significance of the
individual differences to the function and antigenicity of
the viral proteins is not known.
In addition to the N, P, M, and G proteins, ABLV
encodes a large potential open reading frame encoding
a 2127 amino acid polypeptide corresponding to the RNA
polymerase, or L protein, of the rhabdoviruses. This com-
pares with the predicted size of 2127 amino acids for
SAD B19, 2142 amino acids for PV, and 2126–7 amino
acids for Mokola L proteins. There are no other in-frame
initiation codons upstream. The ABLV L protein N-termi-
nal sequence agrees well with the other lyssaviruses for
which there is sequence for this region, and there is
reasonable agreement with local nucleotide preferences
for efficient eukaryotic translation initiation (Kozak, 1986,
1987). The C-terminal residues agree well with the other
lyssaviruses with the one exception of the PV strain that
terminates an additional 15 amino acid residues down-
stream. The predicted L protein has a molecular weight
of 243 kDa, a charge of 16 and an isoelectric point of
8.27.
There are six conserved domains (blocks I to VI)
present in the RNA polymerases of the mononegavirales
group of negative-strand RNA viruses (Poch et al., 1990).
Amino acid sequence motifs that presumably relate to
important functions of the enzyme during replication re-
side within these blocks (Fig. 4). Block I is critical for
multiple polymerase functions (Chandrika et al., 1995)
and has a tripeptide GHP (amino acids 372–4) with an
unknown function that is invariant in negative-strand
RNA viruses. A putative leucine zipper motif, LX6LX6LX6L,
not found in the corresponding region of the L protein of
other lyssaviruses, is present (amino acids 237–58) and
may have some functional role. Blocks II and III comprise
the major functional domains. Block II is rich in basic
residues, and roles as a RNA recognition site or a nu-
cleotide binding site have been suggested for the region.
Premotif A, located between amino acid 543 and 71, is
found in positive and negative RNA viruses and RNA-
dependent polymerases of retroid elements and may be
involved in positioning and binding of the RNA template
(Muller et al., 1994). Block III is highly conserved and has
four motifs, A–D, referred to as the polymerase module.
Motif A, which is present in all known polymerases, is
located at amino acids 610–25. Motif B, which may have
a role in template binding, is found at amino acids 683–
707. Motif C, which is also ubiquitous to the poly-
merases, is located at amino acids 724–34 and contains
the sequence QGDNQ, or core motif. This motif is anal-
ogous to the GDD motif of the positive-stand RNA poly-
merases and has a crucial catalytic role as mutations in
this region abolished rabies and VSV RNA synthesis (Jin
and Elliott, 1992; Sleat and Banerjee, 1993). Motif D,
amino acids 797–809, may have some catalytic role.
The role of block IV is unclear but may be involved in
nucleotide binding (Poch et al., 1990). It is rich in proline
residues that are invariant in negative-strand RNA vi-
ruses (amino acids 896, 917, 964, and 1025) and also has
two conserved dipeptides GG (amino acids 899–900)
and DP (amino acids 916–7). Block V has three invariant
cysteine (amino acids 1093, 1132, and 1320) and three
invariant histidine residues (amino acids 1241, 1312,
1314) that may have a catalytic role via metal binding. A
glycine-rich motif, GXGXG, found in block VI at amino
acids 1704–1708 may be important for polyadenylation or
protein kinase activities. This region is essential for VSV
RNA synthesis (Canter et al., 1993).
Phylogenetic analysis of ABLV
Due to the conservation of polymerase sequences
among distantly related viruses, the L protein, and in
particular the highly conserved domain III, has been
used to elucidate the taxonomic relationships among
mononegavirales. An unrooted phylogenetic tree based
on distance methods using domain III illustrates the
relationship among the rhabdo-virus genera (Fig. 5A). As
would be expected, the genera containing viruses that
infect terrestrial animals—the ephemeroviruses, vesciu-
loviruses, and lyssaviruses—cluster more closely than
those infecting fish (the novirhabdoviruses) and plants
(the nucleorhabdoviruses). Strong bootstrap support
(95) was obtained for the clustering at each of the
nodes separating the genera. ABLV clustered with the
lyssavirus group closest to the rabies virus. Unfortu-
nately, the limited number of lyssaviruses sequenced in
this region of the genome makes a more detailed anal-
ysis difficult. However, the analysis is similar to results
obtained with the nucleocapsid (see below; Gould et al.,
1998).
To elucidate the relationship between ABLV and other
lyssaviruses, a phylogenetic analysis was performed on
the nucleocapsid (Fig. 5B). This region was chosen as
the serological reactivity of the nucleocapsid and is com-
monly used for typing and there is also an abundance of
sequence information for this protein. The analysis was
performed on representatives from each of the lyssavirus
genotypes and included wild and laboratory strains of
rabies (genotype 1). Reasonable support (68) was ob-
tained for the nodal points separating each of the geno-
types. As with the phylogenetic analysis on the L protein,
there was good bootstrap support (89) for clustering of
ABLV with rabies. Interestingly, the pteropid ABLV and
insectivorous isolates appear as quite distinct entities
when the branch lengths separating them is considered.
Reasonable bootstrap support (80) was obtained for
clustering of the human isolate with the pteropid ABLV,
rather than the insectivorous strain. As the patient was
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bitten by an undetermined species of flying fox, this
relationship was not unexpected.
The analysis of the nucleotide sequences of the
pteropid and insectivorous bat isolates of ABLV in this
work indicates considerable differences between these
two viruses. Human rabies immune globulin (HRIG) pro-
FIG. 4. The predicted amino acid sequence of the RNA polymerase of the human isolate of Australian bat lyssavirus. The six conserved domains
(I–VI) are shown (Poch et al., 1990). Conserved blocks are underlined and indicated above (Pre-A and A–D). Invariant conserved residues are
underlined. The leucine zipper motif is indicated by an asterisk (*) placed below the leucine residues.
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tects against infection with pteropid and insectivorous
strains of ABLV (Hanlon et al., 2001). Rabies vaccine
protects against infection with the insectivorous strain
(Hooper et al., 1997). Considering the close genetic and
serological similarity of the pteropid strain and rabies
strains (this work; Gould et al., 1998; Hooper et al., 1997),
it is likely that rabies vaccine affords protection from
infection with the pteropid strain; however, this has never
been demonstrated. To be confident in current preexposure
prophylactic regimes, it will be necessary to determine the
efficacy of rabies vaccine against the pteropid strain.
Divergence estimation for ABLV strains
Recent estimates of mutation rates for the lyssavi-
ruses glycoprotein sequence have been calculated
(Badrane et al., 2001). This enabled an approximate di-
vergence time for the human and insectivorous isolates
to be calculated using substitution values obtained for
the same region with our data. The synonymous substi-
tutions per synonymous site (dS) and the nonsynony-
mous substitutions per site (dN) for the glycoprotein gene
of the insectivorous and human isolates, excluding the
FIG. 5. Phylogenetics analyses on ABLV. Unrooted trees generated by the neighbour-joining method using evolutionary distances calculated from
a multiple sequence alignment of (A) the polymerase module A–D, amino acids Y608–L835 and (B) the complete predicted nucleocapsid amino acid
sequence.
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variable carboxyl-terminal domain, were calculated to be
0.748 and 0.059, respectively. A divergence time of 943
263 and 1695  412 years was calculated from the
values for synonymous and nonsynonymous substitu-
tions, respectively. Due to saturation of synonymous
sites, estimations of divergence based on nonsynony-
mous substitutions are often more reliable over long
evolutionary periods. Hence, the latter figure of approx-
imately 1700 years for divergence of the two strains is
more probable. This analysis indicates that if divergence
of the pteropid and insectivorous strains occurred on
mainland Australia, endemic lyssaviruses have been a
natural feature of the Australian environment for a long
time prior to European colonisation.
The genetic separation of the pteropid and insectivo-
rous bat strains of ABLV suggests two possibilities for
the evolution of the virus in Australia. In the first scenario,
there was a single entry of the virus into Australia fol-
lowed by the evolution of two separate lineages. Using
this scenario we have shown that the virus may have
existed in Australia for approximately 1700 years. In the
second scenario, two separate incursions of the two
strains of ABLV into Australia have occurred. There is
little evidence to discriminate between the two possibil-
ities. The lack of genetic variability in isolates of ABLV
supports a recent incursion of the pteropid strain. The
identification of a gray-headed flying fox (P. poliocepha-
lus) infected with a rhabdovirus in India in 1980 (Pal et al.,
1980) suggests a possible external source of the virus.
Alternatively, the pteropid strain may have been exported
from Australia in recent times. So-called “spill-over”
events have not been documented since European colo-
nisation and the virus has not established itself in wild
and/or domesticated animal populations. This suggests
that spill-over events are probably a rare occurrence. It
will be necessary to obtain additional isolates from Micro-
choptera andMegachiroptera species within Australia, and
related viruses from outside Australia, if these exist, to form
a clearer picture of the origins of the virus. This will be
crucial to determine the risk to human and animal health
and to ascertain the risk of future spillover events.
MATERIALS AND METHODS
Virus and cell culture
Mouse neuroblastoma cells (MNA, BioWhittaker) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with 1% glutamine and 5% fetal calf serum at 37°C under
5% CO2. The source of virus was a section taken from the
right cerebral hemisphere of a 37-year-old woman who
was fatally infected by a bite from a fruit bat (Pteropus
sp.) 27 months previously. Brain material was homoge-
nized, added to MNA cells, and incubated for 8 days.
Virus containing culture supernatant was then passaged
onto fresh MNA cells. After a further 13 days the cell
culture supernatant was collected and stored at 80°C.
Amplification of nucleocapsid to polymerase coding
region
ABLV RNA was extracted from cell culture superna-
tants using the QIAamp viral RNA extraction kit (Qiagen)
according to instructions provided by the manufacturer.
Contiguous overlapping amplification products (Fig. 1,
clones B–N) covering the start of the nucleocapsid to the
start of the polymerase coding regions were obtained
using Titan (Roche) reverse-transcriptase/thermostable
DNA polymerase mix using conditions recommended by
the manufacturer and custom-made primer sets (se-
quences available upon request) with cycling [50°C, 10
min]1[94°C, 10 min]1[95°C, 1 min; 47°C, 1 min; 72°C, 1
min]40[72°C, 10 min]1.
Amplification of polymerase region
cDNA was prepared from the viral RNA using random
primers with Superscript II (Gibco BRL). To obtain ABLV
L protein region sequence, degenerate primers ABL1
(5-AAGAGTGAGATGCWGAGAGC-3) and ABL2 (5-AT-
CATCTCATTGTAAGGATT-3) complementary to an evolu-
tionarily conserved region at the carboxyl-terminal re-
gion of the L-coding region were synthesized. Products
were amplified in reactions containing 2 l of cDNA
template and primers ABL1 and 2 using the thermostable
DNA polymerase DyNAzyme (Finnzymes), under condi-
tions recommended by the manufacturer and cycling
[94°C, 1 min]1[94°C, 20 s; 50°C, 30 s; 72°C, 1
min]35[72°C, 10 min]1. To amplify the 5.8-kb fragment
covering the majority of the L protein region, specific
primers ABL7 (5-CCTCAGGAAAGCCTCTTATAAGATCTT-
GAT-3) and ABL8 (5-AACGGGTCGAATCATCCTAATCAT-
GTAACC-3) were used with the Expand long-PCR sys-
tem (Roche) using recommended conditions, with a hot
start and cycling [94°C, 1 min]1[94°C, 20 s; 65°C, 30 s;
72°C, 5 min]35[72°C, 7 min]1. All reaction products were
visualized by routine agarose gel electrophoresis. Am-
plicons were cloned using the pGEM-T Easy vector sys-
tem (Promega).
Amplification of termini
A fragment containing the 5 terminus was obtained
using the 5/3RACE system (Roche) (Frohman, 1993).
Briefly, the first-strand cDNA product was polyadenylated
with terminal deoxynucleotidyl transferase and then am-
plified with the specific primer ABL5 (5-TTGAACTAT-
CAAGATCTTATA-3) and the supplied oligo(dT)-anchor
primer, under the cycling conditions [94°C, 1 min]1[94°C,
20 s; 55°C, 30 s; 72°C, 1 min]30[72°C, 7 min]1. A second
round of amplification followed using 1 l of diluted
(1:100) first-round product, specific primer ABL6 (5-
AGAGGCTTTCCTGAGGAG-3), and the supplied anchor
primer, with cycling [94°C, 1 min]1[94°C, 20 s; 55°C, 30 s;
72°C, 1 min]30[72°C, 7 min]1. The 3-terminus sequence
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was obtained by polyadenylation of the viral RNA using
poly(A) polymerase (Gibco BRL) followed by cDNA syn-
thesis with the oligo(dT)-anchor primer. The polyadenyl-
ated cDNA was amplified using the specific primer
LYSB2–862 (5-GGATGAGATTGAACACATGGCC-3) and
the anchor primer, with cycling conditions [94°C, 1
min]1[94°C, 20 s; 50°C, 30 s; 72°C, 1.5 min]35[72°C, 7
min]1. One microlitre of the first round product was used
as template for a second round of amplification with
specific primer LYSA2-704 (5-TCTTCATAAGCGGTTAC-
TACC-3) and the anchor primer, with cycling [94°C, 1
min]1[94°C, 20 s; 55°C, 30 s; 72°C, 1 min]30[72°C, 7 min]1.
Sequencing of ABLV
Both strands of either amplicons or plasmid DNA were
sequenced using the Big Dye sequencing mix (Applied
Biosystems) in a reaction containing template and the
relevant sequencing primer on a GeneAmp PCR System
2400 (Applied Biosystems), and cycle sequencing [96°C,
10 s; 50°C, 5 s; 60°C, 4 min]25. Reaction products were
separated and detected on an ABI PRISM 377 DNA
Sequencer. For sequencing long PCR L protein-encoding
products, two independent clones were sequenced us-
ing custom-made primers. Where there was a discrep-
ancy between the sequences, a third clone was se-
quenced to obtain a consensus. For 3- and 5RACE
products, at least 10 independent clones for each termini
were sequenced.
Analysis of viral sequence
Computer analysis was performed using the GCG (Ge-
netics Computer Group, 1994) and EGCG (Rice, 1996)
packages through the Australian National Genomics In-
formation Service (http://www.angis.org.au). Viral RNA
sequence was compiled and edited using the GEL-
ASSEMBLE suite of programs. Nucleotide and dinucleo-
tide composition was analysed by ECOMPOSITION.
Pair-wise alignments of amino acid sequences were
made with GAP and multiple sequence alignments
with PILEUP. Genetic distances were calculated using
EPROTDIST using the Kimura method for proteins. Phylo-
genetic trees were constructed with ENEIGHBOR using
the neighbour-joining method. Bootstrap analysis was
performed on 100 resampled data sets using ESEQBOOT
to generate the data and ECONSENSE to find the con-
sensus tree. Synonymous substitutions per synonymous
site (dS) and nonsynonymous substitutions per nonsyn-
onymous site (dN) were calculated using NEWDIVERGE
that employs the method of Li (Li et al., 1985) with
modifications (Li, 1993; Pamilo and Bianchi, 1993). Diver-
gence times were calculated using either
dN  2rN t or dS  2rS t
for synonymous or nonsynonymous substitutions where
t is time and rS and rN are the rates of synonymous and
nonsynonymous substitution per site, respectively (Nei
and Kumar, 2000). The errors were calculated based on
the lower and higher substitution rates.
The GenBank accession/locus numbers for the se-
quences used in the analysis were as follows: Adelaide
River virus (ARV), AF234534; Australian bat lyssavirus
Ballina pteropid isolate (ABLVp), AF006497; Australian
bat lyssavirus insectivorous isolate (ABLVi), AF08120;
bovine ephemeral fever virus (BEFV), AF234533; Duven-
hage (DUVV), U22848; European bat lyssavirus 1 (FRA),
U22845; European bat lyssavirus 1 (POL), U22844; Euro-
pean bat lyssavirus 2 (FIN), U22846; European bat lys-
savirus 2 (HOL), U22847; infectious haemopoetic necro-
sis virus (IHNV), IHNVRNAGE; Lagos bat virus (LBV),
U22842; Mokola (MOK), MVNPMGLGE and U22843; ra-
bies PV strain (PV), RAVMMGN; rabies RC-HL strain
(RC-HL), AB009663; rabies SAD B-19 (SAD); rice transi-
tory yellowing virus (RTYV), AB011257; snakehead rhab-
dovirus (SHRV), AF147498; sonchus yellow net virus
(SYNV), M87829; vesicular stomatitis virus Indiana sero-
type (VSIV), VSVCG; vesicular stomatitis virus New Jersey
serotype (VSNV), M29788; viral hemorrhagic scepticemia
virus (VHSV), AJ009814. The complete genome-length
sequence for ABLV can be obtained from GenBank with
Accession No. AF418014.
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